✦ LIBER ✦

IM interferon -1a delays definite multiple sclerosis 5 years after a first demyelinating event

Book ID: 125475168
Publisher: Lippincott Williams and Wilkins
Year: 2006
Tongue: English
Weight: 320 KB
Volume: 66
Category: Article
ISSN: 0028-3878
DOI: 10.1212/01.wnl.0000200778.65597.ae

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intramuscular Interferon Beta-1A Therapy

Intramuscular Interferon Beta-1A Therapy Initiated during a First Demyelinating Event in Multiple Sclerosis

✍ Jacobs, Lawrence D.; Beck, Roy W.; Simon, Jack H.; Kinkel, R. Phillip; Brownsche 📂 Article 📅 2000 🏛 Massachusetts Medical Society 🌐 English ⚖ 162 KB

Interferon beta-1a treatment reduces inc

Interferon beta-1a treatment reduces incidence of multiple sclerosis when initiated during first demyelinating event

✍ VONRAISON, F 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 373 KB

Effect of early interferon beta-1a thera

Effect of early interferon beta-1a therapy on conversion to multiple sclerosis in Iranian patients with a first demyelinating event

✍ H. Pakdaman; M. A. Sahraian; A. Fallah; R. Pakdaman; K. Ghareghozli; M. Ghafarpo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 473 KB

OPL068 Recombinant interferon beta or gl

OPL068 Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis: a Cochrane review

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Effect of early versus delayed interfero

Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study

✍ Ludwig Kappos; Mark S Freedman; Chris H Polman; Gilles Edan; Hans-Peter Hartung; 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 183 KB

Comparison of two dosing frequencies of

Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial

✍ Giancarlo Comi; Nicola De Stefano; Mark S Freedman; Frederik Barkhof; Chris H Po 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 224 KB